Palo Alto, CA
,
USA
·
North America
Vivo Capital is a Palo Alto-based global healthcare investment firm focused on biopharmaceuticals and medical technology companies across the US and Asia. The firm invests $10M–$75M at Series A through late stage. Portfolio companies include BeiGene, Gracell, Kineta, and Legend Biotech.
Know when they open it, which slides they read, and when to follow up.
Pitchwise turns every shared deck into a live intelligence feed.
